As previously seen with both FGF19 and FGFR4, EpCAM expression also appeared to increase with the histological severity of inflammation and liver disease, demonstrating a significant positive correlation between EpCAM expression and histopathologic changes from ST to HCC (r = 0.947) (Figure 5). This evidence concerns the gene FGF19 and liver disorder.